FI935318A - 15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa - Google Patents

15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa Download PDF

Info

Publication number
FI935318A
FI935318A FI935318A FI935318A FI935318A FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A
Authority
FI
Finland
Prior art keywords
pergualin
deoxy
analogues
therapy
processes
Prior art date
Application number
FI935318A
Other languages
English (en)
Swedish (sv)
Other versions
FI935318A0 (fi
FI112211B (fi
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of FI935318A0 publication Critical patent/FI935318A0/fi
Publication of FI935318A publication Critical patent/FI935318A/fi
Application granted granted Critical
Publication of FI112211B publication Critical patent/FI112211B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
FI935318A 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet FI112211B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR9214517 1992-12-02

Publications (3)

Publication Number Publication Date
FI935318A0 FI935318A0 (fi) 1993-11-29
FI935318A true FI935318A (fi) 1994-06-03
FI112211B FI112211B (fi) 2003-11-14

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935318A FI112211B (fi) 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet

Country Status (24)

Country Link
US (1) US5476870A (fi)
EP (1) EP0600762B1 (fi)
JP (1) JP2945261B2 (fi)
KR (1) KR100187328B1 (fi)
CN (1) CN1045431C (fi)
AT (1) ATE140215T1 (fi)
AU (1) AU664124B2 (fi)
CA (1) CA2110437C (fi)
CZ (1) CZ284958B6 (fi)
DE (1) DE69303583T2 (fi)
DK (1) DK0600762T3 (fi)
ES (1) ES2092263T3 (fi)
FI (1) FI112211B (fi)
FR (1) FR2698628B1 (fi)
GR (1) GR3021269T3 (fi)
HK (1) HK1000467A1 (fi)
HU (1) HU218908B (fi)
NO (1) NO180483C (fi)
NZ (1) NZ250330A (fi)
RU (1) RU2114823C1 (fi)
SK (1) SK280286B6 (fi)
TW (1) TW311132B (fi)
UA (1) UA39920C2 (fi)
ZA (1) ZA938821B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2187281A1 (en) * 1995-02-10 1996-08-15 Luc Lebreton 15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
EP1107998B1 (en) * 1998-08-28 2004-02-04 Gryphon Sciences Method for the preparation of polyamide chains of precise length, their conjugates with proteins
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
JP5166022B2 (ja) * 2004-05-05 2013-03-21 サイレンス・セラピューティクス・アーゲー 脂質、脂質複合体、およびその使用
KR101366482B1 (ko) 2004-12-27 2014-02-21 사일런스 테라퓨틱스 아게 코팅된 지질 복합체 및 이들의 용도
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
JP5878172B2 (ja) * 2010-07-29 2016-03-08 ラボラトワール フルニエ エスアーエス 炎症性眼疾患の治療/予防用化合物
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
CN1045431C (zh) 1999-10-06
FR2698628A1 (fr) 1994-06-03
FI935318A0 (fi) 1993-11-29
EP0600762A1 (fr) 1994-06-08
CA2110437A1 (en) 1994-06-03
ES2092263T3 (es) 1996-11-16
ZA938821B (en) 1994-06-30
TW311132B (fi) 1997-07-21
DE69303583D1 (de) 1996-08-14
HU9303406D0 (en) 1994-03-28
CZ284958B6 (cs) 1999-04-14
GR3021269T3 (en) 1997-01-31
AU5188393A (en) 1994-06-16
NO934338L (no) 1994-06-03
CN1095709A (zh) 1994-11-30
AU664124B2 (en) 1995-11-02
SK280286B6 (sk) 1999-11-08
HUT65782A (en) 1994-07-28
DE69303583T2 (de) 1996-11-21
JPH06293728A (ja) 1994-10-21
ATE140215T1 (de) 1996-07-15
US5476870A (en) 1995-12-19
CA2110437C (en) 1999-04-13
FR2698628B1 (fr) 1995-02-17
FI112211B (fi) 2003-11-14
RU2114823C1 (ru) 1998-07-10
NO180483C (no) 1997-04-30
EP0600762B1 (fr) 1996-07-10
KR940014435A (ko) 1994-07-18
CZ262293A3 (en) 1994-06-15
SK135793A3 (en) 1994-06-08
HK1000467A1 (en) 1998-03-27
KR100187328B1 (ko) 1999-05-15
HU218908B (hu) 2000-12-28
NO180483B (no) 1997-01-20
UA39920C2 (uk) 2001-07-16
JP2945261B2 (ja) 1999-09-06
NZ250330A (en) 1995-06-27
NO934338D0 (no) 1993-11-30
DK0600762T3 (da) 1996-11-11

Similar Documents

Publication Publication Date Title
LU88670I2 (fr) Fluvastatine eventuellement sous forme de sel par exemple sel de sodium
FI935318A (fi) 15-deoksispergualiinianalogit, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
ES2037666T3 (es) Utilizacion de las fenil-naftiridinas.
ES2146606T3 (es) Metodo para limpiar alfombras.
JPS6419066A (en) Dihydropyridineamides
NZ247608A (en) Dithiolanylglycine-containing hiv protease inhibitors and medicaments
NO871575L (no) Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
GR3022546T3 (en) Inositol phosphate analogues as calcium-antagonistic substances
DE3666223D1 (en) Anticonvulsant agents
HU896173D0 (fi)
FI894653A (fi) Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare.
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK0472181T3 (da) 5-Amino-substituerede adenosinanaloge som immunsuppresiva
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
FI924769A0 (fi) Foerfarande foer framstaellning av substituerade indoler
DE69108139D1 (de) Verwendung von 5'-Vinylhalo-aristeromycin/adenosin-Analoga als Immunsuppressiva.

Legal Events

Date Code Title Description
MA Patent expired